Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2001
11/22/2001WO2001035991A3 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
11/22/2001WO2001034809A3 Staphylococcus epidermidis nucleic acids and proteins
11/22/2001WO2001034805A3 Human vanilloid receptor gene
11/22/2001WO2001034642A3 Control of neisserial membrane synthesis
11/22/2001WO2001032884A3 Educational kit and method containing novel alpha helical protein-34
11/22/2001WO2001031036A3 Modified viral surface proteins which bind to cells of tumor vasculature
11/22/2001WO2001030969A8 Stanniocalcin proteins and nucleic acids and methods based thereon
11/22/2001WO2001029223A3 Type i membrane protein ztsl1
11/22/2001WO2001029183A3 Mutant lactic bacteria with a capacity for overexpressing at least one peptidase
11/22/2001WO2001027269A3 Vip54 protein and related materials
11/22/2001WO2001027268A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
11/22/2001WO2001027255A3 Nucleic acid coding for a ctage gene family, use and production thereof
11/22/2001WO2001027146A3 Chemokine receptor
11/22/2001WO2001023597A9 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
11/22/2001WO2001021795A3 Fatty acid transport proteins
11/22/2001WO2001021631A3 Secreted proteins and uses thereof
11/22/2001WO2001019993A3 Virulence genes of m. marinum and m. tuberculosis
11/22/2001WO2001019380A3 Oncolytic virus
11/22/2001WO2001018542A3 Identification, assessment, prevention, and therapy of ovarian cancer
11/22/2001WO2001018254A3 Mutant of rad51 gene and its use in the diagnosis of predisposition to breast cancer
11/22/2001WO2001018169A3 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases
11/22/2001WO2001015655A3 Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders
11/22/2001WO2001014564A3 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
11/22/2001WO2001011063A3 Gene transfer combination vectors, method for the production and utilization thereof
11/22/2001WO2000070089A9 Cdx2 is downstream mediator of apc tumor suppressor activity
11/22/2001WO2000070022A9 Ex vivo expansion of mammalian hematopoietic stem cells
11/22/2001WO2000055633A9 Methods of screening for colorectal cancer modulators
11/22/2001WO2000014263A9 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
11/22/2001US20010044941 For modulation of corn kernel development and protecting against stress and adverse environmental conditions
11/22/2001US20010044940 Expressed sequences of arabidopsis thaliana
11/22/2001US20010044525 Fibroblast growth factor (FGF); antibodies, expression vectors, fusion proteins; culturing mesenchymal stem cells or progenitor cells in presence of zFGF12 to stimulate cell proliferation
11/22/2001US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
11/22/2001US20010044522 Polypeptides, antibodies against them and nucleic acids encoding them; detecting activated CD4+ T-cells to diagnose a disease or condition of the immune system; screening for immunosuppressants
11/22/2001US20010044418 Treatment of allergies
11/22/2001US20010044414 Inhibiting metastasis in a mammal by administering an agent which alters the actin-based cytoskeleton of tumor cells; inhibiting specified genes involved in metastasis, RhoC for example; predicting likelihood of metastatic condition
11/22/2001US20010044397 Bleaching enzymes and detergent compositions comprising them
11/22/2001US20010044150 Method for transformation of animal cells
11/22/2001US20010044149 Transfer of heterologous gene sequences into cells using equine infectious anemia virus-derived vectors for gene delivery
11/22/2001US20010044148 EBV-infected stomach cancer cell line
11/22/2001US20010044146 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
11/22/2001US20010044144 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
11/22/2001US20010044135 Chimeric molecules and novel assay system
11/22/2001US20010044134 Cytokines; transcription factors; for detection of cancer, genetic abnormalities
11/22/2001US20010044133 Phage-dependent super-production of biologically active protein and peptides
11/22/2001US20010044130 G-protein-coupled receptors; receptor binding assay; polypeptides; antibodies; drug screening
11/22/2001US20010044120 Useful for the prevention or treatment of peptic ulcers in humans or mammals.
11/22/2001US20010044118 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD
11/22/2001US20010044110 Inhibition of mal1
11/22/2001US20010043935 Use of polyamino acid derivatives to treat seborrhoea and the associated skin disorders
11/22/2001US20010043931 (HRSV); Drug screening for a drug that inhibits the virus' membrane fusion machinery, such as drugs that bind the N-helix coiled-coil of HRSV and thus inhibit infection; vaccines, antibodies
11/22/2001US20010043930 Method for treating cervical dystonia with botulinum toxin type B
11/22/2001US20010043922 Recombinants of the multiply deficient adenoviral vectors; a therapeutic method and their use particularly relating to gene therapy and vaccination
11/22/2001US20010043920 Delivering a dosage of a growth factor-encoding transgene composition to preselected delivery sites in the brain where the encoded growth factor is expressed and stimulates axonal growth; mimimally invasive; Alzheimer's, Parkinson diseases
11/22/2001US20010043917 Bacteriophage modified by serial passageing or genetic engineering so the modified bacteriophage will remain active in the body for a longer time than the wild-type phage; infections
11/22/2001DE10032630A1 Vector encoding an expansin, useful in treatment of cellulosic materials for paper recycling, providing large-scale production
11/22/2001DE10024989A1 DNA from the jellyfish Turritopsis nutricula useful as a rejuvenation agent for human beings
11/22/2001DE10009119A1 Vertebraten Globin Vertebrate globin
11/22/2001CA2410181A1 Novel motor proteins and methods for their use
11/22/2001CA2410056A1 Induction of apoptosis and cell growth inhibition by protein 4.33
11/22/2001CA2409746A1 Immunotoxin fusion proteins and means for expression thereof
11/22/2001CA2409705A1 Gene responsible for stargardt-like dominant macular dystrophy
11/22/2001CA2409506A1 Method for cell adhesion and wound healing
11/22/2001CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001CA2409164A1 Novel nucleic acids and polypeptides
11/22/2001CA2409108A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001CA2409077A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators
11/22/2001CA2409031A1 Insecticidal secreted proteins of brevibacillus laterosporus
11/22/2001CA2408827A1 Novel human lipocalin homologs and polynucleotides encoding the same
11/22/2001CA2408745A1 Anti-angiogenic polypeptides
11/22/2001CA2408691A1 Compositions and methods for achieving immune suppression
11/22/2001CA2408617A1 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001CA2408503A1 Seven transmembrane proteins and polynucleotides encoding the same
11/22/2001CA2408433A1 Synthetic gagpol genes and their uses
11/22/2001CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
11/22/2001CA2408373A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001CA2408246A1 Cell line for the expression of an .alpha.2.delta.2 calcium channel subunit
11/22/2001CA2408134A1 G-protein coupled receptors
11/22/2001CA2407707A1 In vitro fucosylation recombinant glycopeptides
11/22/2001CA2398979A1 Novel bee venom polypeptides and methods of use thereof
11/22/2001CA2384561A1 Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins
11/21/2001EP1156123A1 Method for detecting a variation of GH1 as indicator of growth hormone dysfunction
11/21/2001EP1156119A2 Anti-cancer gene therapy by modulation of immune or inflammatory response
11/21/2001EP1156118A1 Virus vector
11/21/2001EP1156116A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defense
11/21/2001EP1156115A1 Corynebacterium glutamicum strain with enhanced secretion activity
11/21/2001EP1156112A1 Synthetic gagpol genes and their uses
11/21/2001EP1156111A1 Chimeric arterivirus-like particles
11/21/2001EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001EP1156109A1 MYC targets
11/21/2001EP1156102A1 Immunodeficiency virus recombinant poxvirus vaccine
11/21/2001EP1156063A1 Antibodies to the granulocyte colony stimulating factor receptor
11/21/2001EP1156061A1 Reagent for the diagnosis of rheumatoid arthritis
11/21/2001EP1155706A1 Apparatus for production of fibrin glue and its medical application
11/21/2001EP1155700A2 Lymphocyte chemoattractant factor and uses thereof
11/21/2001EP1155691A2 Anti-angiogenic compositions and methods of use
11/21/2001EP1155690A2 Anti-angiogenic compositions and method of use
11/21/2001EP1155689A2 Anti-angiogenic compositions and methods of use
11/21/2001EP1155379A1 Determining protein function and interaction from genome analysis
11/21/2001EP1155322A1 COMPOUNDS AND METHODS FOR THE DETECTION AND PREVENTION OF $i(T. CRUZI) INFECTION